These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33831519)

  • 1. Twenty-Four-Month Outcomes of Drug-Coated Balloon in Diabetic Patients in the BIOLUX P-III Registry: A Subgroup Analysis.
    Mwipatayi BP; Barry IP; Brodmann M; Zeller T; Varcoe RL; Moscovic M; Chian JWC; Christensen JK; Yahaya SA; Oshin OA; Tepe G;
    Ann Vasc Surg; 2021 Aug; 75():237-252. PubMed ID: 33831519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry.
    Tepe G; Zeller T; Moscovic M; Corpataux JM; Christensen JK; Keirse K; Nano G; Schroeder H; Binkert CA; Brodmann M
    J Endovasc Ther; 2020 Apr; 27(2):304-315. PubMed ID: 31989855
    [No Abstract]   [Full Text] [Related]  

  • 3. BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries.
    Tepe G; Wang J; Corpataux JM; Pua U; Binkert CA; Moscovic M; Ghotbi R; Keirse K; Robertson D; Brodmann M
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):10-18. PubMed ID: 32964317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis.
    Barry IP; Macarulay R; Brodmann M; Zeller T; Moscovic M; Dahm J; Troisi N; Tepe G; Wong J; Mwipatayi BP;
    Cardiovasc Intervent Radiol; 2022 Jul; 45(7):918-928. PubMed ID: 35445317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Experience With a Paclitaxel-Coated Balloon in Critical Limb Ischemia: 24-Month Subgroup Outcomes of BIOLUX P-III.
    Brodmann M; Moscovic M; Wang JCC; Nano G; Dahm J; Zeller T; Christensen JK; Keirse K; Ghotbi R; Corpataux JM; Tepe G
    JACC Cardiovasc Interv; 2020 Oct; 13(19):2289-2299. PubMed ID: 32950415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Coated Balloon for the Treatment of Long-Segment Femoropopliteal Artery Disease: Pooled Analysis from the BIOLUX P-III SPAIN and BIOLUX P-III All-Comers Registry Long Lesion Subgroup.
    Angel de Gregorio M; Brodmann M; Ruiz EM; Manteca JC; Salmeron RR; Munoz Ruiz-Canela JJ; Trujillo IG; Tepe G
    J Vasc Interv Radiol; 2023 Oct; 34(10):1707-1715.e7. PubMed ID: 37422253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry.
    Tepe G; Zeller T; Moscovic M; Corpataux JM; Christensen JK; Keirse K; Nano G; Schroeder H; Binkert CA; Brodmann M
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):207-217. PubMed ID: 33083853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon.
    Thieme M; Von Bilderling P; Paetzel C; Karnabatidis D; Perez Delgado J; Lichtenberg M;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1682-1690. PubMed ID: 28780030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lutonix® 014 DCB global Below the Knee Registry Study: interim 6-month outcomes.
    Thieme M; Lichtenberg M; Brodmann M; Cioppa A; Scheinert D
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):232-236. PubMed ID: 29363894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 13. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
    JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Effectiveness of Passeo-18 Lux Drug-Coated Balloon Catheter in Infrainguinal Endovascular Revascularization in the Korean Population: A Multicenter Post-Market Surveillance Study.
    Choi TW; Won JH; Jae HJ; Jeon YS; Park SW; Ko GY; Yim NY; Won JY; Kim CW; Kim J
    Korean J Radiol; 2024 Jun; 25(6):565-574. PubMed ID: 38807338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
    Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
    Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
    JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia.
    Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.
    Chen Z; Guo W; Jiang W; Wang F; Fu W; Zou Y; Deckers S; Li P; Popma JJ; Jaff MR
    J Endovasc Ther; 2019 Aug; 26(4):471-478. PubMed ID: 31204595
    [No Abstract]   [Full Text] [Related]  

  • 20. Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.
    Deloose K; Bosiers M; Peeters P; Verbist J; Maene L; Beelen R; Keirse K; Hendriks J; Lauwers P; Wauters J; Verschueren M
    J Endovasc Ther; 2020 Dec; 27(6):936-945. PubMed ID: 32873131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.